Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1992 Mar;51(3):384–388. doi: 10.1136/ard.51.3.384

Microalbuminuria in systemic sclerosis.

A Dawnay 1, A G Wilson 1, E Lamb 1, J D Kirby 1, W R Cattell 1
PMCID: PMC1004667  PMID: 1575587

Abstract

A prospective study was performed to determine urinary albumin excretion in a group of 28 patients with systemic sclerosis. At the initial screen one patient had proteinuria and three had microalbuminuria. One year later these abnormalities persisted and in two of of the patients serum creatinine had significantly increased. In addition, a further three patients had developed microalbuminuria. In a control group of 10 patients with primary Raynaud's disease none had microalbuminuria. In a second control group of 16 patients with unrelated skin diseases one patient had microalbuminuria and one proteinuria, but both these patients had a history of hypertension. It is concluded that microalbuminuria is more common in patients with systemic sclerosis than in patients of equivalent age with other dermatological conditions but no vascular disease.

Full text

PDF
384

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borch-Johnsen K., Kreiner S. Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J (Clin Res Ed) 1987 Jun 27;294(6588):1651–1654. doi: 10.1136/bmj.294.6588.1651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bulpitt C. J., Beilin L. J., Clifton P., Coles E. C., Dollery C. T., Gear J. S., Harper G. S., Johnson B. F., Munro-Faure A. D. Risk factors for death in treated hypertensive patients. Report from the D.H.S.S. Hypertension Care Computing Project. Lancet. 1979 Jul 21;2(8134):134–137. doi: 10.1016/s0140-6736(79)90013-8. [DOI] [PubMed] [Google Scholar]
  3. Christensen C. K., Lederballe Pedersen O., Mikkelsen E. Renal effects of acute calcium blockade with nifedipine in hypertensive patients receiving beta-adrenoceptor-blocking drugs. Clin Pharmacol Ther. 1982 Nov;32(5):572–576. doi: 10.1038/clpt.1982.205. [DOI] [PubMed] [Google Scholar]
  4. Corcoran J. S., Perkins J. E., Hoffbrand B. I., Yudkin J. S. Treating hypertension in non-insulin-dependent diabetes: a comparison of atenolol, nifedipine, and captopril combined with bendrofluazide. Diabet Med. 1987 Mar-Apr;4(2):164–168. doi: 10.1111/j.1464-5491.1987.tb00855.x. [DOI] [PubMed] [Google Scholar]
  5. Damsgaard E. M., Frøland A., Jørgensen O. D., Mogensen C. E. Microalbuminuria as predictor of increased mortality in elderly people. BMJ. 1990 Feb 3;300(6720):297–300. doi: 10.1136/bmj.300.6720.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Deckert T., Feldt-Rasmussen B., Borch-Johnsen K., Jensen T., Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia. 1989 Apr;32(4):219–226. doi: 10.1007/BF00285287. [DOI] [PubMed] [Google Scholar]
  7. Feldt-Rasmussen B. Increased transcapillary escape rate of albumin in type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia. 1986 May;29(5):282–286. doi: 10.1007/BF00452063. [DOI] [PubMed] [Google Scholar]
  8. Grenfell A., Watkins P. J. Clinical diabetic nephropathy: natural history and complications. Clin Endocrinol Metab. 1986 Nov;15(4):783–805. doi: 10.1016/s0300-595x(86)80074-3. [DOI] [PubMed] [Google Scholar]
  9. Jarrett R. J., Viberti G. C., Argyropoulos A., Hill R. D., Mahmud U., Murrells T. J. Microalbuminuria predicts mortality in non-insulin-dependent diabetics. Diabet Med. 1984 May;1(1):17–19. doi: 10.1111/j.1464-5491.1984.tb01915.x. [DOI] [PubMed] [Google Scholar]
  10. Jayson M. I. Systemic sclerosis: a collagen or microvascular disease? Br Med J (Clin Res Ed) 1984 Jun 23;288(6434):1855–1857. doi: 10.1136/bmj.288.6434.1855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jensen T., Bjerre-Knudsen J., Feldt-Rasmussen B., Deckert T. Features of endothelial dysfunction in early diabetic nephropathy. Lancet. 1989 Mar 4;1(8636):461–463. doi: 10.1016/s0140-6736(89)91365-2. [DOI] [PubMed] [Google Scholar]
  12. Kannel W. B., Stampfer M. J., Castelli W. P., Verter J. The prognostic significance of proteinuria: the Framingham study. Am Heart J. 1984 Nov;108(5):1347–1352. doi: 10.1016/0002-8703(84)90763-4. [DOI] [PubMed] [Google Scholar]
  13. Mimran A., Insua A., Ribstein J., Monnier L., Bringer J., Mirouze J. Contrasting effects of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. J Hypertens. 1988 Nov;6(11):919–923. doi: 10.1097/00004872-198811000-00011. [DOI] [PubMed] [Google Scholar]
  14. Mogensen C. E., Chachati A., Christensen C. K., Close C. F., Deckert T., Hommel E., Kastrup J., Lefebvre P., Mathiesen E. R., Feldt-Rasmussen B. Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest. 1985;9(2):85–95. doi: 10.3109/08860228509088195. [DOI] [PubMed] [Google Scholar]
  15. Mogensen C. E., Christensen C. K. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med. 1984 Jul 12;311(2):89–93. doi: 10.1056/NEJM198407123110204. [DOI] [PubMed] [Google Scholar]
  16. Oliver J. A., Cannon P. J. The kidney in scleroderma. Nephron. 1977;18(3):141–150. doi: 10.1159/000180805. [DOI] [PubMed] [Google Scholar]
  17. Parving H. H., Mogensen C. E., Jensen H. A., Evrin P. E. Increased urinary albumin-excretion rate in benign essential hypertension. Lancet. 1974 Jun 15;1(7868):1190–1192. doi: 10.1016/s0140-6736(74)91002-2. [DOI] [PubMed] [Google Scholar]
  18. Reams G. P., Hamory A., Lau A., Bauer J. H. Effect of nifedipine on renal function in patients with essential hypertension. Hypertension. 1988 May;11(5):452–456. doi: 10.1161/01.hyp.11.5.452. [DOI] [PubMed] [Google Scholar]
  19. Rowe D. J., Dawnay A., Watts G. F. Microalbuminuria in diabetes mellitus: review and recommendations for the measurement of albumin in urine. Ann Clin Biochem. 1990 Jul;27(Pt 4):297–312. doi: 10.1177/000456329002700404. [DOI] [PubMed] [Google Scholar]
  20. Seibold J. R. Digital sclerosis in children with insulin-dependent diabetes mellitus. Arthritis Rheum. 1982 Nov;25(11):1357–1361. doi: 10.1002/art.1780251112. [DOI] [PubMed] [Google Scholar]
  21. Silver A., Dawnay A., Landon J., Cattell W. R. Immunoassays for low concentrations of albumin in urine. Clin Chem. 1986 Jul;32(7):1303–1306. [PubMed] [Google Scholar]
  22. Viberti G. C., Hill R. D., Jarrett R. J., Argyropoulos A., Mahmud U., Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet. 1982 Jun 26;1(8287):1430–1432. doi: 10.1016/s0140-6736(82)92450-3. [DOI] [PubMed] [Google Scholar]
  23. Yudkin J. S., Forrest R. D., Jackson C. A. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet. 1988 Sep 3;2(8610):530–533. doi: 10.1016/s0140-6736(88)92657-8. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES